Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.
Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Yamazaki R, et al. Among authors: nishida j. Transpl Infect Dis. 2014 Dec;16(6):904-13. doi: 10.1111/tid.12304. Epub 2014 Nov 4. Transpl Infect Dis. 2014. PMID: 25367140
L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation.
Kimura SI, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Oshima K, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Kimura SI, et al. Among authors: nishida j. Transpl Infect Dis. 2012 Aug;14(4):364-73. doi: 10.1111/j.1399-3062.2012.00727.x. Epub 2012 Apr 3. Transpl Infect Dis. 2012. PMID: 22469427
Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y. Kawamura K, et al. Among authors: nishida j. Transpl Infect Dis. 2013 Oct;15(5):457-65. doi: 10.1111/tid.12118. Epub 2013 Jul 29. Transpl Infect Dis. 2013. PMID: 23895431
Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.
Nakasone H, Tanaka Y, Yamazaki R, Terasako K, Sato M, Sakamoto K, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y. Nakasone H, et al. Among authors: nishida j. Bone Marrow Transplant. 2014 Jan;49(1):87-94. doi: 10.1038/bmt.2013.122. Epub 2013 Aug 12. Bone Marrow Transplant. 2014. PMID: 23933763
Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.
Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y. Sato M, et al. Among authors: nishida j. Bone Marrow Transplant. 2014 Apr;49(4):553-60. doi: 10.1038/bmt.2013.217. Epub 2014 Jan 13. Bone Marrow Transplant. 2014. PMID: 24419514
Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, Ishihara Y, Kawamura K, Akahoshi Y, Hayakawa J, Wada H, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y. Terasako-Saito K, et al. Among authors: nishida j. Transpl Infect Dis. 2014 Dec;16(6):930-40. doi: 10.1111/tid.12318. Epub 2014 Nov 28. Transpl Infect Dis. 2014. PMID: 25430567
Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y. Kikuchi M, et al. Among authors: nishida j. Transpl Infect Dis. 2015 Feb;17(1):56-65. doi: 10.1111/tid.12345. Epub 2015 Jan 12. Transpl Infect Dis. 2015. PMID: 25580541
Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
Kimura S, Oshima K, Sato K, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Kimura S, et al. Among authors: nishida j. Biol Blood Marrow Transplant. 2010 Oct;16(10):1355-61. doi: 10.1016/j.bbmt.2010.04.012. Epub 2010 May 10. Biol Blood Marrow Transplant. 2010. PMID: 20457267 Free article.
Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation.
Yamazaki R, Nakasone H, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kikuchi M, Kimura S, Okuda S, Kako S, Tanaka Y, Tanihara A, Oshima K, Nishida J, Kanda Y. Yamazaki R, et al. Among authors: nishida j. Exp Hematol. 2011 Dec;39(12):1119-23. doi: 10.1016/j.exphem.2011.09.002. Epub 2011 Sep 10. Exp Hematol. 2011. PMID: 21911093 Free article.
433 results